Background {#Sec1}
==========

Scrub typhus is a mite-borne infectious disease caused by a bacteria called *Orientia tsutsugamushi*, previously known as *Rickettsia tsutsugamushi* \[[@CR1]\]. It is one of the emerging infectious diseases of Nepal \[[@CR2]\]. Clinical manifestation of scrub typhus includes a painless papule called *eschar* representing localized cutaneous necrosis at the site of infecting chigger bite, followed by fever, generalized headache, diffuse myalgia, anorexia, generalized lymphadenopathy, and non-pruritic body rash. However, it can present with atypical signs and symptoms such as those of acute kidney injury, gastroenteritis, rarely pneumonitis, and acute respiratory distress syndrome. Meningitis, encephalitis, and hepatic dysfunction have been reported too, particularly in severe cases, with multisystem involvement \[[@CR3]\]. Case fatality rate of scrub typhus is 6% for untreated and 1.4% for treated cases \[[@CR1]\].^,^ \[[@CR4]\] Therefore, a high degree of clinical suspicion is required for the diagnosis of scrub typhus which can be confirmed by a rapid diagnostic test or polymerase chain reaction (PCR); Indirect immunofluorescence assay (IFA) being the gold standard test---a four-fold rise in IgM antibody titer is usually diagnostic of infection \[[@CR5]\]. Unfortunately, in low-resource settings, it may take several weeks just to get the test results. Scrub typhus is commonly treated with doxycycline, a highly effective antibiotic given for 1 week.

Scrub typhus has never been reported in the literature to cause urinary tract infections (UTIs) which includes cystitis (infection of the bladder or lower urinary tract) and pyelonephritis (infection of the kidney or upper urinary tract). UTI is usually caused by *Escherichia coli* and rarely by other uropathogens such as other Enterobacteriaceae (*Klebsiella* spp. and *Proteus* spp.*)*, *Pseudomonas*, enterococci, and staphylococci \[[@CR6]\]. Generally, the patients with UTI present with fever and occasionally with chills or rigors, fatigue or malaise, flank pain, costovertebral angle tenderness, and pelvic or perineal pain. Pyelonephritis can develop if pathogens ascend to the kidneys either via ureters or through the lymphatics \[[@CR7]\].

Case presentation {#Sec2}
=================

A 45 year-old male patient presented to the outpatient unit of Internal Medicine Department in September 2019 with complaints of fever, abdominal pain (right flank), and burning micturition for 3 days. He was otherwise well in the past and none of his family members had similar illness. On physical examination, he had normal temperature, blood pressure, pulse rate, and respiratory rate. On systemic examination, he had tenderness at his right renal angle. Respiratory, cardiovascular, and neurological examinations were unremarkable. There were no rash, lymphadenopathy or hepatosplenomegaly.

On urine investigation, 1--2 pus cells were seen per high power field (hpf) but no red blood cells (RBC). Total white cell count (TC) including differential counts (DC), hemoglobin (Hb), platelet count, and erythrocyte sedimentation rate (ESR) were within normal limits. His blood creatinine level was 0.9 mg/dL, urea was 33 mg/dL, sodium 142 mmol/L and potassium 4.8 mmol/L. Urine and blood culture was ordered. (Table [1](#Tab1){ref-type="table"}*)* Ultrasonography (US) of his abdomen-pelvis showed mild fatty changes in liver, right renal concretions, and prostatomegaly (approx. 26.59 g). The patient was sent home on oral cefixime 400 mg twice daily, oral diclofenac 75 mg thrice daily, and hyoscine tablet 20 mg thrice daily. Table 1Laboratory investigation timeline and reports (abnormal values are marked in bold)Laboratory parametersNormal values\
(KMC\
Lab protocol)Day 1Day 4Day 5Day 6Day 7\
*(Doxycycline added)*Day 8Day 10Day 17**Hematology** TC (cells/mm^3^)3500-10,500**10,70014,80012,20011,10011,40012,50012,400**7400 DC (%)N60--80, L20--30, E1--4**N82L13**N66L24 **E10N83 L15N87L12**N80**L17**N71 L27N73 L22N67 L26 Hb (gm/dL)12--1613.413.7**11.010.810.411.210.711.7** Platelets (cells/mm^3^)150,000-450,000192,000190,000**115,000120,000145,000**212,000232,000490,000 ESR (mm/hr)\< 15**41Renal panel** Urea (mg/dL)15--452930252229183333 Creatinine (mg/dL)0.5--1.21.0**1.51.3**1.21.21.01.00.9 Sodium (mmol/L)135--145138135136136136138138142 Potassium (mmol/L)3.5--5.03.73.83.8**3.43.1**3.53.54.8**Liver panel** Total Bilirubin mg/dL)0.2--1.2**1.7** Direct Bilirubin (mg/dL)0--0.4**1.0** SGPT/SGOT (IU/L)\< 45 each32/16 ALP (IU/L)50--100**521** Albumin (gm/dL)3.5--5.0 PT/INR (sec)11.0--13.5/0.8--1.2**15.0/1.17Urine examination** Urine pus cells (per hpf)\< 1--2**10--12plenty**0--2 Urine RBCnilnilnil Urine albuminnilnilnil Urine cultureno growthno growthno growth**Other blood tests** Random sugar (mg/dL)60--1409981 Serum Lipase/Amylase (U/L)10--160/25--11015/25 Blood cultureno growth**Tropical panel serology** Scrub typhus**positive (rapid IgM)** Leptospiranegative Denguenegative Leishmaniasisnegative Malaria (optimal test)negative

On Day 4, the patient returned to the outpatient unit with persistent symptoms. He was then admitted to the medical ward with intravenous (IV) ceftriaxone 1 g twice daily, Injection tramadol for pain, and intravenous fluids. Urine and blood culture reports showed no growth of pathogens. Routine laboratory investigations were repeated. Urine showed plenty pus cells but no RBCs, sugar and albumin. Serum creatinine level increased to 1.5 mg/dL whereas blood urea (30 mg/dL), sodium (135 mmol/L), and potassium (3.8 mmol/L) levels decreased. Liver panel (transaminases, total and direct bilirubin, alkaline phosphate, serum lipase, serum amylase) was normal. (Table [1](#Tab1){ref-type="table"}*).*

The patient continued to be symptomatic on Day 5 of illness despite IV medication. Routine urine and blood investigations came out unremarkable except for a sudden decrease in platelet count (190,00 on Day 4 to 115,000 on Day 5) and serum creatinine level (1.5 on Day 4 to 1.3 on Day 5). (Table [1](#Tab1){ref-type="table"}*)* Follow-up US abdomen-pelvis showed globular right kidney with probe tenderness, suggestive of acute pyelonephritis. Antibiotics were then upgraded to IV meropenem and IV teicoplanin.

A plain computer tomography scan of the patient's kidneys-ureters-bladder (CT-KUB) showed right perirenal haziness and fatty strandings; thickened right lateral conal fascia with minimal surrounding haziness but no evidence of hydroureteronephrosis; tiny renal concretions, splenunculus, and plate atelectasis in the posterobasal segment of right lower lobe of right kidney; and mild degenerative changes in the visualized spine. These findings complemented the US diagnosis of acute pyelonephritis. *(*Fig. [1](#Fig1){ref-type="fig"}*).*Fig. 1CT scan kidneys-ureters-bladder findings (on Day 5 of illness). Right kidney (R) has perirenal haziness and fatty stranding (arrow); thickened right lateral conal fascia with minimal surrounding haziness; tiny renal concretions, spenunculus, and plate atelectasis in the postero-basal segment of right lower lobe; mild degenerative changes visualized in spine. Left kidney (L) is normal

On Day 7 of illness, the patient was still complaining right flank pain along with fever. He suddenly became tachypneic with respiratory rate of 24/min. An urgent US chest was performed which showed minimal bilateral pleural effusion. Routine laboratory investigations came out unremarkable except for decreasing creatinine level (1.2 mg/dL). (Table [1](#Tab1){ref-type="table"}*)* Then, a possibility of serositis was suspected.

Kathmandu city was hit by dengue epidemic at the time of the patient's hospital admission. Therefore, a possibility of tropical fever in this patient was thought of too. His blood samples were sent for the investigation for dengue virus, scrub typhus, leptospirosis, leishmaniasis (kala-azar), and malaria (optimal test). All tests came out negative except for scrub typhus --IgM antibodies positive on rapid diagnostic test. Immediately, doxycycline (100 mg IV twice daily) was added to the patient's medication list (Day 7 of illness).

The patient's clinical features and lab results did not change remarkably for 36 h of initiating doxycycline. However, over the next 48 h (Day 10 onwards), the patient showed clinical improvement. His fever and abdominal pain decreased significantly. On Day 12 of illness (9th day of admission, 7th day of IV meropenem, 5th day of IV doxycycline), the patient had a feeling of well-being, so he was sent home with oral doxycycline for 10 additional days and oral levofloxacin for 7 days.

When the patient visited hospital after 6 days of discharge (Day 17), he was found apparently asymptomatic; all blood and urine investigations came out normal; and his follow-up ultrasonography findings (chest-abdomen-pelvis) were non-significant.

Discussion and conclusions {#Sec3}
==========================

Renal abnormalities in scrub typhus case range from proteinuria or hematuria to acute kidney injury and occasionally chronic kidney disease \[[@CR8]\]. Acute pyelonephritis in scrub typhus has been reported only once in the literature---in a 56-year-old Chinese lady who presented with frequent micturition, flank pain, and an *eschar* in her body \[[@CR9]\]. The mechanisms postulated for renal involvement include typhus-related vasculitis, tubular interstitial proliferation, and tubular necrosis \[[@CR8]\].

In the current case, poor control of symptoms with oral and intravenous antibiotics (cefixime, ceftriaxone, meropenem and teicoplanin), abnormal laboratory and radiographic reports suggestive of multiorgan involvement (decreasing platelet counts, decreasing creatinine, deranged liver panel, globular right kidney, bilateral pleural effusion), and an ongoing tropical fever epidemic in Kathmandu prompted the clinicians to investigate for an atypical causative agent.

Positive rapid serological test (IgM antibodies against scrub typhus) confirmed the diagnosis. All investigation reports including US chest-abdomen-pelvis drastically came out normal, with no evidence of pyelonephritis, after 10 days of initiating doxycycline (Day 17 of onset of illness). Moreover, patient's fever did not recur even after discontinuing other intravenous antibiotics, favoring scrub typhus diseaseccc rather than systemic bacterial sepsis.

Acute febrile illness can present with atypical clinical signs and symptoms, often with multisystem involvement, that should urge clinicians to look for atypical pathogens---for example scrub typhus associated with pyelonephritis in this case. Scrub typhus is a common but neglected tropical disease in South Asia including Nepal. Therefore, stakeholders should not wait until an outbreak or epidemic occurs to initiate standard surveillance programs, deploy reliable and affordable diagnostic kits at all levels of healthcare service, and raise community awareness about disease transmission and preventive measures.

ALP

:   Alkaline phosphatase

CT

:   Computerized tomography

DC

:   Differential count

ESR

:   Erythrocyte sedimentation rate

Hb

:   Hemoglobin

IFA

:   Immunofluorescence assay

KMC

:   Kathmandu medical college

KUB

:   Kidneys-ureters-bladder

PCR

:   Polymerase chain reaction

PT/INR

:   Prothrombin time/International normalized ratio

SGPT/SGOT

:   Serum glutamic pyruvic transaminase/oxaloacetic transaminase

TLC

:   Total leucocyte count

UTI

:   Urinary tract infection

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

We would like to appreciate Professor Dr. Arpana Neopane and her team who provided valued support and guidance during the treatment of the patient. We also thank the patient for providing us with written informed consent for the case study and its publication.

TB, SCP, and NP were involved in patient treatment. TB and NP collected samples and laboratory reports. SB supervised the study. TB and SB interpreted test results, and wrote the first manuscript draft. All authors reviewed and approved the final version of manuscript.

None.

All the information supporting our conclusions and relevant references are included in the manuscript. There are no datasets related to this case report.

Institutional ethical approval is generally not required for case reports in our setting. The patient provided informed consent in written form to participate in this study.

The patient authorized the main author, in written form, to publish this case report and the accompanying image (CT KUB). A copy of the consent is available for review by the journal editor

All authors declare that they have no competing interests.
